Zobrazeno 1 - 10 of 190 pro vyhledávání: '"MS Anscher"'
2
Editorial & Opinion
The professional radiation workforce in the United States.
Autor: Newhauser WD; Department of Physics and Astronomy, Louisiana State University and Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, USA., Williams JP; University of Rochester Medical Center, Rochester, New York, USA., Noska MA; U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Borrás C; Georgetown University, Washington, DC, USA., Holahan EV; U.S. Nuclear Regulatory Commission, Washington, DC, USA., Dewji SA; Georgia Institute of Technology, Nuclear and Radiological Engineering and Medical Physics Programs, George W. Woodruff School of Mechanical Engineering, Atlanta, Georgia, USA., Johnson TE; Colorado State University, Fort Collins, Colorado, USA., Hiatt JW; Nuclear Energy Institute, Washington, DC, USA., Poston JW; Texas A&M University, 3133 TAMU, College Station, Texas, USA., Hertel N; Georgia Institute of Technology, North Avenue Atlanta, Atlanta, Georgia, USA., Gress DA; American College of Radiology, Reston, Virginia, USA., Mills MD; James Graham Brown Cancer Center, Louisville, Kentucky, USA., Jordan DW; University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Sutlief SG; Banner MD Anderson Cancer Center, Phoenix, Arizona, USA., Martin MC; Therapy Physics Inc., Gardena, California, USA., Jackson E; University of Wisconsin, Madison, Wisconsin, USA., Bluth EI; Ochsner Clinic Foundation, New Orleans, Louisiana, USA., Frush DP; Childrens Health Center, Duke University, Durham, North Carolina, USA., Oates ME; University of Kentucky, Lexington, Kentucky, USA., LaBerge J; University of California, San Francisco, California, USA., Pan HY; Sutter Radiation Oncology Center, Sacramento, California, USA., Rosenthal SA; Sutter Radiation Oncology Center, Roseville, California, USA., Townsend LW; University of Tennessee, Knoxville, Tennessee, USA., Brady L; Nuclear Energy Institute, Washington, DC, USA., Lindegard J; American Nuclear Society, La Grange Park, Illinois, USA., Hall HL; University of Tennessee, Knoxville, Tennessee, USA., McAndrew-Benavides E; Electric Power Research Institute, Palo Alto, California, USA., Abelquist E; Oak Ridge Associated Universities, Oak Ridge, Tennessee, USA., Anscher MS; Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Vazquez M; Loma Linda University, Loma Linda, California, USA., Kronenberg A; Lawrence Berkeley National Laboratory, Berkeley, California, USA., Willey JS; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Lawrence T; University of Michigan - University Hospital, Ann Arbor, Michigan, USA., Woloschak GE; Northwestern University, Chicago, Illinois, USA., Marples B; University of Rochester Medical Center, Rochester, New York, USA., Wong R; National Cancer Institute, Rockville, Maryland, USA., Story M; The University of Texas Southwestern, Dallas, Texas, USA., Howell RW; Rutgers New Jersey Medical School, Newark, New Jersey, USA., Hei TK; Columbia University, New York, New York, USA., Tolmachev SY; Washington State University, Richland, Washington, USA., Auxier JD; University of Tennessee, Knoxville, Tennessee, USA., Rucker TL; Leidos, Reston, Virginia, USA., Nilsson M; University of California, Irvine, California, USA., Sudowe R; Colorado State University, Fort Collins, Colorado, USA., Powell BA; Clemson University, Anderson, South Carolina, USA., Jensen MP; Colorado School of Mines, Golden, Colorado, USA.
Publikováno v: Journal of applied clinical medical physics [J Appl Clin Med Phys] 2022 Dec; Vol. 23 Suppl 1, pp. e13848.
Zobrazit plný text záznamu
3
Akademický článek
Radiation biology workforce in the United States.
Autor: Williams JP; Departments of Environmental Medicine and Radiation Oncology, University of Rochester Medical Center, Rochester, New York, USA., Anscher MS; Department of Radiation Oncology, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Vazquez M; Department of Radiation Medicine, Radiation Research Division, Loma Linda University, Loma Linda, California, USA., Kronenberg A; Biological Systems and Engineering Division, Lawrence Berkeley National, Laboratory, Berkeley, California, USA., Willey JS; Department of Radiation Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Lawrence T; Department of Radiation Oncology, University of Michigan - University Hospital, Ann Arbor, Michigan, USA., Woloschak GE; Departments of Radiation Oncology, Radiology, and Cell and Molecular Biology, Northwestern University, Chicago, Illinois, USA., Marples B; Department of Radiation Oncology, University of Rochester Medical Center, Rochester, New York, USA., Wong R; National Cancer Institute, Rockville, Maryland, USA., Howell RW; Chief, Division of Radiation Research, Department of Radiology, Center for Cell Signaling, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Publikováno v: Journal of applied clinical medical physics [J Appl Clin Med Phys] 2022 Dec; Vol. 23 Suppl 1, pp. e13743.
Zobrazit plný text záznamu
4
Editorial & Opinion
Summary and conclusions, and abbreviations and acronyms.
Autor: Newhauser WD; Department of Physics & Astronomy, Louisiana State University and Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana, USA., Williams JP; University of Rochester Medical Center, Rochester, New York, USA., Noska MA; U.S. Food & Drug Administration, Silver Spring, Maryland, USA., Borrás C; Georgetown University, Washington, District of Columbia, USA., Holahan EV; U.S. Nuclear Regulatory Commission, Washington, District of Columbia, USA., Dewji SA; Department of Nuclear Engineering, Texas A&M University, College Station, Texas, USA., Johnson TE; Colorado State University, Fort Collins, Colorado, USA., Hiatt JW; Nuclear Energy Institute, Washington, District of Columbia, USA., Poston JW; Texas A&M University, College Station, Texas, USA., Hertel N; Georgia Institute of Technology, North Avenue Atlanta, Atlanta, Georgia, USA., Gress DA; American College of Radiology, Reston, Virginia, USA., Mills MD; James Graham Brown Cancer Center, Louisville, Kentucky, USA., Jordan DW; University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Sutlief SG; Banner MD Anderson Cancer Center, Phoenix, Arizona, USA., Martin MC; Therapy Physics Inc., Gardena, California, USA., Jackson E; University of Wisconsin, Madison, Wisconsin, USA., Bluth EI; Ochsner Clinic Foundation, New Orleans, Louisiana, USA., Frush DP; Duke University, Childrens Health Center, Durham, North Carolina, USA., Oates ME; University of Kentucky, Lexington, Kentucky, USA., LaBerge J; University of California, San Francisco, San Francisco, California, USA., Pan HY; Anderson Cancer Center, Houston, Texas, USA., Rosenthal SA; Sutter Radiation Oncology Center, Roseville, California, USA., Townsend LW; University of Tennessee, Zeanah Engineering Complex, Knoxville, Tennessee, USA., Brady L; Nuclear Energy Institute, Washington, District of Columbia, USA., Lindegard J; American Nuclear Society, La Grange Park, Illinois, USA., Hall HL; University of Tennessee, Zeanah Engineering Complex, Knoxville, Tennessee, USA., McAndrew-Benavides E; Electric Power Research Institute, Palo Alto, California, USA., Abelquist E; Oak Ridge Associated Universities, Oak Ridge, Tennessee, USA., Anscher MS; Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA., Vazquez M; Loma Linda University, Loma Linda, California, USA., Kronenberg A; Lawrence Berkeley National Laboratory, Berkeley, California, USA., Willey JS; Wake Forest School of Medicine, Winston-Salem, North Carolina, USA., Lawrence T; University of Michigan-University Hospital, Ann Arbor, Michigan, USA., Woloschak GE; Northwestern University, Chicago, Illinois, USA., Marples B; University of Rochester Medical Center, Rochester, New York, USA., Wong R; National Cancer Institute, Rockville, Maryland, USA., Story M; The University of Texas Southwestern, Dallas, Texas, USA., Howell RW; Rutgers New Jersey Medical School, Newark, New Jersey, USA., Hei TK; Columbia University, New York, New York, USA., Tolmachev SY; Washington State University, Richland, Washington, USA., Auxier JD; University of Tennessee, Ferris, Knoxville, Tennessee, USA., Rucker TL; Leidos, Reston, Virginia, USA., Nilsson M; University of California, Irvine, Irvine, California, USA., Sudowe R; Colorado State University, Fort Collins, Colorado, USA., Powell BA; Clemson University, Rich Lab, Anderson, South Carolina, USA., Jensen MP; Colorado School of Mines, Golden, Colorado, USA.
Publikováno v: Journal of applied clinical medical physics [J Appl Clin Med Phys] 2022 Dec; Vol. 23 Suppl 1, pp. e13846.
Zobrazit plný text záznamu
5
Akademický článek
Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy: A Pooled Analysis of Trials in the US Food and Drug Administration Database.
Autor: Anscher MS; US Food and Drug Administration, Silver Spring, Maryland., Arora S; US Food and Drug Administration, Silver Spring, Maryland., Weinstock C; US Food and Drug Administration, Silver Spring, Maryland., Amatya A; US Food and Drug Administration, Silver Spring, Maryland., Bandaru P; Palantir Technologies, Inc, Washington, DC., Tang C; University of Texas MD Anderson Cancer Center, Houston., Girvin AT; Palantir Technologies, Inc, Washington, DC., Fiero MH; US Food and Drug Administration, Silver Spring, Maryland., Tang S; US Food and Drug Administration, Silver Spring, Maryland., Lubitz R; Palantir Technologies, Inc, Washington, DC., Amiri-Kordestani L; US Food and Drug Administration, Silver Spring, Maryland., Theoret MR; US Food and Drug Administration, Silver Spring, Maryland., Pazdur R; US Food and Drug Administration, Silver Spring, Maryland., Beaver JA; US Food and Drug Administration, Silver Spring, Maryland.
Publikováno v: JAMA oncology [JAMA Oncol] 2022 Feb 01; Vol. 8 (2), pp. 232-240.
Zobrazit plný text záznamu
6
Akademický článek
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy.
Autor: Prasanna PG; National Cancer Institute, NIH, Bethesda, MD, USA., Citrin DE; National Cancer Institute, NIH, Bethesda, MD, USA., Hildesheim J; National Cancer Institute, NIH, Bethesda, MD, USA., Ahmed MM; National Cancer Institute, NIH, Bethesda, MD, USA., Venkatachalam S; National Cancer Institute, NIH, Bethesda, MD, USA., Riscuta G; National Cancer Institute, NIH, Bethesda, MD, USA., Xi D; National Cancer Institute, NIH, Bethesda, MD, USA., Zheng G; College of Pharmacy, University of Florida, Gainesville, FL, USA., Deursen JV; Rochester, MN, USA., Goronzy J; Department of Medicine, Stanford University, Stanford, CA, USA., Kron SJ; The University of Chicago, Chicago, IL, USA., Anscher MS; U.S. Food and Drug Administration, Silver Spring, MD, USA., Sharpless NE; National Cancer Institute, NIH, Bethesda, MD, USA., Campisi J; Buck Institute for Research on Aging, Novato, CA, USA., Brown SL; Henry Ford Hospital, Detroit, MI, USA., Niedernhofer LJ; Institute on the Biology of Aging and Metabolism, Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., O'Loghlen A; Epigenetics & Cellular Senescence Group; Blizard Institute; Barts and The London School of Medicine and Dentistry; Queen Mary University of London, 4 Newark Street, London, E1 2AT, UK., Georgakilas AG; DNA Damage Laboratory, Physics Department, School of Applied Mathematical and Physical Sciences, National Technical University of Athens (NTUA), Zografou, 15780, Athens, Greece., Paris F; Universite de Nantes, INSERM, CNRS, CRCINA, Nantes, France., Gius D; University of Texas Southwestern Medical Center, Dallas, TX, USA., Gewirtz DA; Virginia Commonwealth University, Richmond, VA, USA., Schmitt CA; Charité - Universitätsmedizin, 13353, Berlin, Germany., Abazeed ME; Johannes Kepler University, 4020, Linz, Austria.; Department of Radiation Oncology, Northwestern, Chicago, IL, USA., Kirkland JL; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN, USA., Richmond A; Department of Pharmacology and Department of Veterans Affairs, Vanderbilt University, Nashville, TN, USA., Romesser PB; Translational Research Division, Department of Radiation Oncology and Early Drug Development Service, Department of Medicine, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lowe SW; Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, and Howard Hughes Medical Institute, New York, NY, USA., Gil J; MRC London Institute of Medical Sciences (LMS), and Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, Du Cane Road, London, W12 ONN, UK., Mendonca MS; Departments of Radiation Oncology & Medical and Molecular Genetics, Indiana University School of Medicine, IUPUI, Indianapolis, IN 46202, USA., Burma S; Departments of Neurosurgery and Biochemistry & Structural Biology, University of Texas Health Science Center, San Antonio, TX, USA., Zhou D; College of Pharmacy, University of Florida, Gainesville, FL, USA., Coleman CN; National Cancer Institute, NIH, Bethesda, MD, USA.
Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Oct 01; Vol. 113 (10), pp. 1285-1298.
Zobrazit plný text záznamu
7
Akademický článek
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Autor: Fallah J; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA. Electronic address: jaleh.fallah@fda.hhs.gov., Zhang L; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Amatya A; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Gong Y; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., King-Kallimanis B; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Bhatnagar V; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Weinstock C; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Suzman DL; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Agrawal S; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Chang E; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Anscher MS; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Chi DC; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Xu JX; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Brewer JR; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Brave MH; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Hadadi M; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Theoret MR; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Kluetz PG; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Goldberg KB; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Ibrahim A; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Tang S; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Pazdur R; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Beaver JA; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA., Amiri-Kordestani L; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA., Singh H; Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD, USA; Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v: The Lancet. Oncology [Lancet Oncol] 2021 Sep; Vol. 22 (9), pp. 1230-1239. Date of Electronic Publication: 2021 Jul 23.
Zobrazit plný text záznamu
8
Editorial & Opinion
Impact of Definitive Local Therapy in Men with Primary Small Cell Prostate Carcinoma.
Autor: Oke O; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ranasinghe W; Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tang C; Division of Genitourinary Radiation/Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Shaaban S; Division of Genitourinary Radiation/Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiao L; Division of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Reichard CA; Division of Urology/Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Anscher MS; Division of Genitourinary Radiation/Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chapin BF; Division of Urology/Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aparicio A; Division of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: aaparicio@mdanderson.org.
Publikováno v: European urology [Eur Urol] 2021 Sep; Vol. 80 (3), pp. 389-390. Date of Electronic Publication: 2021 Apr 03.
Zobrazit plný text záznamu
9
Akademický článek
Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial.
Autor: Wages NA; Division of Translational Research & Applied Statistics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address: nwages@virginia.edu., Sanders JC; Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia., Smith A; Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia., Wood S; Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia., Anscher MS; Department of Radiation Oncology, Virginia Commonwealth University School of Medicine, Richmond, Virginia., Varhegyi N; Division of Translational Research & Applied Statistics, Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia., Krupski TL; Department of Urology, University of Virginia School of Medicine, Charlottesville, Virginia., Harris TJ; Department of Radiation Oncology, Virginia Commonwealth University School of Medicine, Richmond, Virginia., Showalter TN; Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia.
Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2021 Apr 01; Vol. 109 (5), pp. 1254-1262. Date of Electronic Publication: 2020 Nov 21.
Zobrazit plný text záznamu
10
Akademický článek
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer.
Autor: Anscher MS; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Chang E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gao X; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gong Y; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Weinstock C; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bloomquist E; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Adeniyi O; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Charlab R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Zimmerman S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Serlemitsos-Day M; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ning YM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Mayrosh R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Fuller B; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Trentacosti AM; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Gallagher P; Center for Devices and Radiologic Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bijwaard K; Center for Devices and Radiologic Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Philip R; Center for Devices and Radiologic Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ghosh S; Center for Devices and Radiologic Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Fahnbulleh F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Diggs F; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Arora S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Goldberg KB; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Tang S; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Amiri-Kordestani L; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Pazdur R; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Ibrahim A; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Beaver JA; Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v: The oncologist [Oncologist] 2021 Feb; Vol. 26 (2), pp. 139-146. Date of Electronic Publication: 2020 Nov 17.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje